Work

Abstract 337: Highly potent, bispecific ADCs by application of clinical stage GlycoConnect® technology to bYlok® antibodies

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-337

Authors: Floris van Delft, Lianne Lelieveldt, Jasper van de Sande, Anette Sommer

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627435

Cites:

Cited by:

Related to: 10